title: Spontaneous regression of metastatic papillary renal cell cancer after cessation of treatment with sorafenib.
authors.affiliation: Department of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel. talgrenader65@hotmail.com
authors.forename: Tal
authors.initials: T
authors.lastname: Grenader
authors.forename: Eli
authors.initials: E
authors.lastname: Rosenbaum
authors.forename: Sofia
authors.initials: S
authors.lastname: Zilber
authors.forename: Naama
authors.initials: N
authors.lastname: Bogot
authors.forename: Linda
authors.initials: L
authors.lastname: Shavit
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D009362:Neoplasm Metastasis / Q000188:drug therapy; D009536:Niacinamide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010671:Phenylurea Compounds / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D012075:Remission, Spontaneous; D000077157:Sorafenib
chemical_list: D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D047428:Protein Kinase Inhibitors; D009536:Niacinamide; D000077157:Sorafenib